Suchergebnisse - "QALYs"

PubPharm (39)

1

Cost-effectiveness analysis of different screening strategies for helicobacter pylori infection in Iran : A model-based evaluation

enthalten in: Helicobacter | 2023

von Yousefi, M. | Rezaei, S. | Khoshbaten, M. | +1

2

Analytical Frameworks and Outcome Measures in Economic Evaluations of Digital Health Interventions : A Methodological Systematic Review

enthalten in: Medical decision making : an international journal of the Society for Medical Decision Making | 2023

von Benedetto, V. | Filipe, L. | Harris, C. | +3

3

The Merits, Limitations, and Future Directions of Cost-Effectiveness Analysis in Cardiac MRI with a Focus on Coronary Artery Disease : A Literature Review

enthalten in: Journal of cardiovascular development and disease | 2022

von Siddiqui, T. | Chamarti, K. | Tou, L. | +4

4

Use of the incremental cost-effectiveness ratio for decision-making policies-what is the problem? A perspective paper

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2022

von Brougham, M. | Schlander, M. | Telser, H. | +2

ErratumIn: Expert Rev Pharmacoecon Outcomes Res. 2022 Jul 21;:1. - PMID 35861375

5

Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients

enthalten in: Frontiers in oncology | 2022

von Li, W. | Guo, H. | Li, L. | +1

6

First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma : A cost-effectiveness analysis from China

enthalten in: Frontiers in pharmacology | 2022

von Shen, J. | Du, Y. | Shao, R. | +1

7

Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients

in: Frontiers in Oncology | 2022

von Wenqian Li | Hanfei Guo | Lingyu Li | +1

8

The Merits, Limitations, and Future Directions of Cost-Effectiveness Analysis in Cardiac MRI with a Focus on Coronary Artery Disease: A Literature Review

in: Journal of Cardiovascular Development and Disease | 2022

von Taha A. Siddiqui | Kiran S. Chamarti | Leila C. Tou | +4

9

Cycle-network expansion plan in Oslo : Modeling cost-effectiveness analysis and health equity impact

enthalten in: Health economics | 2021

von Lamu, A. | Norheim, O. | Gregersen, F. | +1

10

Biologics for severe, chronic plaque psoriasis : An Australian cost-utility analysis

enthalten in: JAAD international | 2021

von Sun, H. | Keller, E. | Suresh, H. | +1